S&P 500
5,966.75
-0.1%
-$4.06
DJI
42,487.72
+0.1%
+$59.98
NASDAQ
19,428.09
-0.2%
-$32.40
Bitcoin
103,137.00
-2.0%
-2,086.41
AAPL
$202.56
-0.1%
-$0.26
AMZN
$209.77
+1.2%
+$2.54
GOOG
$171.47
+1.2%
+$2.08
META
$688.88
+0.1%
+$0.93
MSFT
$469.22
+1.2%
+$5.35
NVDA
$140.86
-0.7%
-$1.06
TSLA
$295.73
-10.9%
-$36.32
Lixte Biotechnology (NASDAQ: LIXT)
$1.38
(-0.6%)
-$0.01
Price as of June 5, 2025, 2:16 p.m. ET
Lixte Biotechnology Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Lixte Biotechnology Company Info
Lixte Biotechnology Holdings, Inc. is a clinical-stage pharmaceutical company. It engages in the business of utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on August 9, 2005 and is headquartered in Pasadena, CA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.